Ampera Life Africa Ltd is a company registered in Nigeria and operates the Ampera Life Africa commercialization platform, connecting diagnostic innovation with governments, healthcare providers, researchers and commercial partners.
Accelerate adoption of innovative precision diagnostic technologies across Africa by connecting governments, healthcare providers, researchers, investors, universities and commercial partners into a collaborative ecosystem enabling earlier detection, better decisions, stronger public-health systems and sustainable commercialization.
Build Africa’s leading precision diagnostics commercialization platform, transforming healthcare through early disease detection, scientific innovation and strategic partnerships that improve human health, strengthen food security, protect animal health and support sustainable economic development.
Ampera Life Africa Ltd works in partnership with Ampera Life Inc. in connection with the development and commercialization of precision diagnostics opportunities across African markets. Ampera Life Inc. owns and develops its underlying technology and intellectual property unless otherwise expressly stated.
Select opportunities around country needs, relevant biomarkers, scientific readiness, buyer demand and feasible implementation.
Develop country-level pathways with appropriate clinical, research, public-health and commercial stakeholders.
Plan evidence generation, quality, training, support and relevant approvals before scaling an intended use.
Explore a collaboration pathway that fits your institution and country priorities.